Status:
COMPLETED
A Dose-response Study of Lidocaine and Etomidate
Lead Sponsor:
West China Hospital
Conditions:
Etomidate Overdose of Undetermined Intent
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
Brief Summary
IV lidocaine administration can reduce the minimal amount of Etomidate and time for induction of anesthesia.
Detailed Description
The study was carried out in West China Hospital of Sichuan University, Chengdu, China. All the patients were informed in detail about the procedure and the medications they are going to get. Patients...
Eligibility Criteria
Inclusion
- Patients scheduled for Elective Surgery,
- age limit within 18-70 years,
- American Society of Anaesthesiologists physical status classification I-II
Exclusion
- Adrenal Cortex disorder,
- Neurologic disease,
- Psychiatric disorders,
- Allergic to Local anesthetic drugs,
- Patients who have received sedatives,analgesics or opioids within the previous 24 hrs.
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01916642
Start Date
April 1 2013
End Date
July 1 2013
Last Update
August 5 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.